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To estimate the effects of women’s weight changes in four sequential perinatal periods across first and second 
pregnancies (pregravid, first gestation, interpregnancy, second gestation) on adverse maternal and neonatal 
outcomes in the second pregnancy while accounting for interdependencies in weight across the four periods 
(Aim 1) and to test the influence of the sequential path of weight changes through the four perinatal periods of 
risk on maternal and neonatal outcomes in the second pregnancy (Aim 2). 
Design 
Secondary data analysis. 
Setting 
Thirty-one Wisconsin hospitals. 
Sample 
Women with 24,795 linked records from first and second births from 2006 through 2013. 
Methods 
We used a fully recursive system of linear and logistic regression equations to examine the relationships among 
weight changes in the four perinatal periods with maternal (gestational diabetes mellitus, gestational 
hypertension, cesarean birth) and neonatal (macrosomia, small for gestational age, large for gestational age, low 
birth weight, congenital anomalies, and perinatal death) adverse outcomes in the second pregnancy. 
Results 
Pregravid weight was weakly and inconsistently associated with weight changes in subsequent periods. Each 5-
kg incremental weight change in the first pregnancy, interpregnancy, and second pregnancy contributed to a 
0.75- to 5-kg weight change in subsequent periods, 9% to 25% change in risk for adverse maternal outcomes, 
and 8% to 47% change in risk for adverse neonatal outcomes in the second pregnancy. Fluctuations in weight 
across pregnancies and associations with outcomes were strongest among normal-weight and overweight 
women. 
Conclusion 
Weight changes across two pregnancies affected maternal and neonatal outcomes in the second pregnancy in 
all body mass index categories; the larger weight fluctuations observed in normal and overweight women were 
associated with greater risk of adverse outcomes. Attention to pregnancy weight during and between 
pregnancies is important for targeted weight counseling to reduce risks in subsequent pregnancies. 
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Research and practice guidelines about women’s weight have largely focused on pre-pregnancy body mass index 
(BMI) and gestational weight gain (GWG) as risks and mediating factors for birth outcomes (American College of 
Obstetricians and Gynecologists, 2013). The effect of women’s cycling up and down in weight across multiple 
pregnancies has received little attention, yet evidence about the role of weight fluctuation could inform clinical 
practice and contribute to more refined risk prediction and weight management approaches to improve 
maternal and infant outcomes of multiparous women. 
The concept of perinatal periods of risk (CityMatCH, n.d.) is a useful framework through which to study changes 
in women’s weight associated with childbearing. For women with two pregnancies, four periods of weight-
related risk exist during the perinatal cycle: pregravid, first gestation, interpregnancy, and second gestation. 
Weight changes in each period have the potential for independent and sequential effects on the health of the 
woman and her newborn, yet the full sequential relationship of each of these interdependent maternal weight 
changes across two pregnancies has not yet been examined. 
Women’s weight changes before pregnancy and during the first gestation, interpregnancy, and the 
second gestation can introduce risks for adverse second pregnancy outcomes. 
Relationships between weight changes across the four perinatal risk periods are complex and interdependent. 
More than 50% of women in the United States are overweight or obese before pregnancy. Although overweight 
and obese women gain less gestational weight than normal-weight women, they are more likely to exceed 
clinical recommendations for GWG (Gunderson, 2009, Rasmussen and Yaktine, 2009). Forty-eight percent of U.S. 
women exceed pregnancy weight gain recommendations (Centers for Disease Control and Prevention, n.d.), and 
excessive GWG in one pregnancy was linked to increased risk of excessive GWG in subsequent pregnancies (Chin 
et al., 2010). High pregravid BMI and excessive GWG have independent associations and jointly exacerbate 
increased weight retention after birth (Endres et al., 2015, Gunderson, 2009, Martin et al., 2014, Nehring et al., 
2011, Siega-Riz et al., 2009). 
Studies on the associations between weight changes and maternal and neonatal outcomes have focused on 
women’s weight during only one or two of the perinatal periods of risk, and most researchers examined same-
pregnancy outcomes. For example, pregravid obesity was associated with elevated risk of gestational diabetes 
mellitus, gestational hypertension, preeclampsia, and cesarean birth (Stubert et al., 2018, Tabet et al., 2015); 
fetal, neonatal, and infant deaths (Chu et al., 2007; Johansson et al., 2014, Stubert et al., 2018, Tabet et al., 
2015); birth weight, macrosomia, and large-for-gestational-age (LGA) infants (Monte et al., 2011, Rowlands 
et al., 2010); hypoglycemia (Collins, Oehmen, & Mehta, 2018); and neural tube, heart, and other structural 
anomalies (Correa and Marcinkevage, 2013, Stothard et al., 2009). However, studies of the effects of pregravid 
weight have frequently not accounted for the correlation between pregravid BMI and GWG, even though 
excessive GWG was also independently linked to greater incidence of preeclampsia, cesarean birth, and LGA 
infants (McDowell, Cain, & Brumley, 2019). In three population-based studies of subsequent pregnancy 
outcomes, interpregnancy weight increase from the beginning of the first pregnancy to the beginning of the 
next pregnancy of 2 to 3 BMI points was linked to a two- to threefold increase in the odds of gestational 
diabetes, gestational hypertension, and cesarean birth (Bogaerts et al., 2013, Villamor and Cnattingius, 
2006, Wallace et al., 2016), newborn macrosomia (Bogaerts et al., 2013, Wallace et al., 2016), LGA newborns, 
and stillbirth (Cnattingius and Villamor, 2016, Villamor and Cnattingius, 2006, Wallace et al., 2016). Notably, the 
relationship between interpregnancy weight increase and maternal and neonatal outcomes was evident in 
underweight and normal-weight women. However, in each of these studies, the researchers did not report 
separate effects of each individual weight period across the two pregnancies. 
Longitudinal studies that incorporate weight data from all perinatal periods are needed to better understand the 
effect of the full weight trajectory on subsequent health outcomes of women and neonates. The purpose of this 
study was to estimate the effects of women’s weight changes in four sequential perinatal periods across first 
and second pregnancies (pregravid, first gestation, interpregnancy, second gestation) on adverse maternal and 
neonatal outcomes in the second pregnancy while accounting for interdependencies in weight across the four 
periods. The specific aims of the analysis were to estimate the sequential path of women’s weight changes 
through the four perinatal periods of risk across two pregnancies (Aim 1) and to test the influence of the 
sequential path of weight changes through the four perinatal periods of risk on maternal and neonatal outcomes 
in the second pregnancy (Aim 2; see Figure 1). 
 
Figure 1. Model of the direct and sequential effects of perinatal weight periods of risk on maternal and neonatal 
outcomes in the second pregnancy. 
Methods 
Design and Setting 
We used data from PeriData.net, a Web-based data platform developed by the Wisconsin Association for 
Perinatal Care, which contained data from 87 of 100 birth hospitals (92% of total births) in Wisconsin from 2006 
through 2013. At the time of data extraction in March 2013, the PeriData.net system included 414,017 birth 
records. Thirty-one hospitals agreed to provide limited data sets to create the study database, which included 
236,820 (57%) birth records. Approval was obtained from the Marquette University institutional review board 
(IRB); IRB determinations were obtained from participating hospitals or deferred to the primary IRB. 
Sample 
We linked births for the same woman that occurred in any of the hospitals included in the data set. The analysis 
was restricted to women for whom data were available for the first and second birth and in which each 
pregnancy resulted in a singleton birth between 20 and 42 weeks gestation (N = 29,090 women). See 
the Supplemental Appendix for a detailed description of sample derivation. After excluding observations with 
missing data, our final sample consisted of 24,795 women. Multiple imputation of missing values produced 
nearly identical results, which are not reported here. 
Measures 
Outcome measures 
We created the following dichotomous maternal and neonatal health measures: gestational diabetes; 
gestational hypertension; cesarean birth; LGA and small for gestational age (SGA), calculated according to Talge, 
Mudd, Sikorskii, and Basso (2014); macrosomia (birth weight > 4,000 g); low birth weight (<2,500 g); the 
presence of any congenital anomalies; and perinatal death defined as stillborn or neonatal death before the 
time of maternal discharge after birth. 
Weight measures 
We constructed four measures of weight changes in kilograms: pregravid weight for the first pregnancy, GWG 
during the first pregnancy (P1 GWG), interpregnancy weight loss, and GWG during second pregnancy (P2 GWG). 
Pregravid weight was the woman’s weight before pregnancy as recorded in PeriData.net by the birth hospitals. 
This information was derived from prenatal records submitted by maternity care providers in preparation for 
birth. Pregravid weight was self-reported to the maternity care provider or measured at the first prenatal visit. 
P1 GWG and P2 GWG were calculated as weight at birth minus pregravid weight for the same pregnancy. 
Weight at birth was measured on admission in labor or recorded from the weight at the last prenatal visit, 
depending on the practice at the birth hospital. Interpregnancy weight loss was calculated as the woman’s 
weight at birth of P1 minus the woman’s pregravid weight for P2. 
Control variables 
We controlled for gestational age at birth in P1 and P2 and the interpregnancy interval (months from P1 birth to 
P2 birth, minus gestational age in P2). Additionally, we used the following maternal demographic characteristics 
from P2 data as controls: age, marital status (yes/no), race (White, Black, Asian, American Indian/Native 
America, Hawaiian/Pacific Islander, and other), Hispanic ethnicity (yes/no), participation in the Special 
Supplemental Nutrition Program for Women, Infants, and Children (yes/no), type of health insurance (private, 
Medicaid, other public, or uninsured/self-pay), education level (less than high school, completed high school, 
partial college, completed 4-year college, graduate degree), use of tobacco during pregnancy (yes/no), use of 
alcohol during pregnancy (yes/no), and height in inches. 
Analysis 
We conducted all analyses with the use of Stata Version 14 (StataCorp, 2015). We calculated summary statistics 
for the outcome measures and weight in each perinatal period and presented them in tabular form (see Table 1) 
for all women in the sample and by pregravid BMI category (P1) using guidelines from the National Heart, Lung, 
and Blood Institute (1998). The underweight category was a small proportion of the total sample (n = 1,154, 
4.65%); therefore, we included underweight in the normal-weight category (BMI < 25 kg/m2) for the analyses. 
Maternal demographic controls are presented in the Supplemental Appendix. 
  
Table 1. Sample Characteristics by Pregravid BMI Categories 
 
All Women (N = 24,795) Pregravid BMI     
Underweight/Normal 
Weight: BMI < 
25.0 kg/m2 (n = 14,566) 
Overweight: BMI = 
25.0–29.9 kg/m2 (n = 
5,866) 
Obese: BMI ≥ 
30.0 kg/m2 (n = 
4,363) 
Weight in kg, mean (SD)     
 Pregravid weight 68.53 (16.83) 58.46 (7.35) 73.41 (7.48) 95.58 (15.88) 
 Gestational weight gain in Pregnancy 1 15.35 (6.76) 15.93 (6.01) 15.95 (6.90) 12.60 (8.13) 
 Interpregnancy weight loss 12.26 (9.05) 12.70 (8.16) 12.56 (8.97) 10.41 (11.44) 
 Pre-Pregnancy 2 weight 71.62 (18.32) 61.69 (9.96) 76.80 (11.64) 97.77 (18.60) 
 Pregravid weight change (pre-Pregnancy 2 
weight – Pregnancy 1 weight) 
3.09 (8.52) 3.23 (7.36) 3.39 (8.81) 2.20 (11.26) 
 Gestational Weight Gain in Pregnancy 2 13.17 (6.63) 13.78 (5.81) 13.32 (7.02) 10.95 (8.05) 
Height in cm, mean (SD) 164.39 (7.56) 164.48 (7.74) 164.36 (7.24) 164.13 (7.35) 
Gestational age in Pregnancy 1 in weeks, mean 
(SD) 
38.96 (2.20) 38.98 (2.10) 39.05 (2.07) 38.77 (2.64) 
Interpregnancy interval in months, mean (SD) 20.61 (13.20) 20.76 (13.15) 20.57 (13.14) 20.17 (13.16) 
Gestational age in Pregnancy 2 in weeks, mean 
(SD) 
38.85 (1.73) 38.83 (1.81) 38.94 (1.63) 38.70 (2.04) 
Maternal/neonatal outcomes in Pregnancy 
1, n (%) 
    
 Gestational diabetes 778 (314) 281 (1.93) 199 (3.39) 298 (6.83) 
 Gestational hypertension 1,829 (7.38) 748 (5.14) 492 (8.39) 589 (13.50) 
 Cesarean 5,423 (21.87) 2,488 (17.08) 1,446 (24.65) 1,489 (34.13) 
 Any congenital anomalies 718 (2.90) 398 (2.73) 174 (2.97) 146 (3.35) 
 Perinatal death 199 (0.80) 99 (0.68) 40 (0.68) 60 (1.38) 
 Large for gestational age 2,171 (8.76) 990 (6.80) 636 (10.84) 545 (12.49) 
 Macrosomia 2,013 (8.12) 928 (6.37) 581 (9.90) 504 (11.55) 
 Small for gestational age 2,669 (10.76) 1,692 (11.62) 542 (9.24) 435 (9.97) 
 Low birth weight 1,679 (6.77) 1,003 (6.89) 341 (5.81) 335 (7.68) 
Maternal/neonatal outcomes in Pregnancy 
2, n (%) 
    
 Gestational diabetes 1,170 (4.72) 452 (3.10) 306 (5.22) 412 (9.44) 
 Gestational hypertension 1,128 (4.55) 451 (3.10) 305 (5.22) 372 (8.53) 
 Cesarean 5,936 (23.94) 2,719 (18.67) 1,560 (26.59) 1,657 (37.98) 
 Any congenital anomalies 667 (2.69) 398 (2.73) 147 (2.51) 122 (2.80) 
 Perinatal death 113 (0.46) 53 (0.36) 22 (0.38) 38 (0.87) 
 Large for gestational age 3,194 (12.88) 1,512 (10.38) 894 (15.24) 788 (18.06) 
 Macrosomia 2,694 (10.87) 1,298 (8.91) 759 (12.94) 637 (14.60) 
 Small for gestational age 1,808 (7.29) 1,186 (8.14) 362 (6.17) 260 (5.96) 
 Low birth weight 1,144 (4.61) 723 (4.96) 227 (3.87) 194 (4.45) 
Note. From Wisconsin Births in the PeriData.net Database, 2006 through 2013. BMI = body mass index; SD = standard deviation. 
  
We jointly tested the sequential path of maternal weight changes through the perinatal periods (Aim 1) and the 
influence on P2 outcomes (Aim 2) using a fully recursive simultaneous equations system. This analytic method 
allowed us to examine the direct and indirect relationships among the weight variables and the outcomes in a 
system of equations representing these interrelated sequential paths of influence. (Clayton & Pett, 2011). For 
example, pregravid weight affects P1 outcomes (e.g., cesarean birth) directly and indirectly through P1 GWG, 
and both of these paths contribute to P2 GWG and sequentially to P2 outcomes. The full conceptual model for 
the analysis is presented in Figure 1, and the full analytic model with all variables is included in the Supplemental 
Appendix in Figure A1. 
We used linear and logistic regression models for continuous (weight) and binary (outcomes) variables, 
respectively. Regression coefficients (for weight measures) represent absolute effect sizes measured in 
kilograms for ease of interpretation. Odds ratios are reported for occurrences of maternal and neonatal 
outcomes. All models included the full set of control variables. 
We selected maternal characteristics for inclusion with the use of a backward stepwise elimination process using 
Stata’s stepwise backward selection command and 0.05 significance (Afifi et al., 2012, Hosmer et al., 
2013, Lindsey and Sheather, 2010). We excluded those that were not individually statistically significant and did 
not improve the model F statistic in any of the equations from the model. 
We estimated the full simultaneous equations model using the seemingly unrelated estimation technique 
(“suest” command) with robust standard errors that accounted for hospital-level clustering and the interrelated 
nature of the error terms among the equations (Weesie, 1999). We used hospital-level fixed effects to account 
for hospital-specific contextual factors. We conducted all tests using standard hypothesis testing techniques and 
a variance–covariance matrix of regression coefficients that included within- and between-equations parameter 
estimates, thus adjusting for multiple hypothesis testing (Clogg, Petkova, & Haritou, 1995). 
Normal-weight and overweight women had greater weight fluctuations than obese women, and these 
fluctuations were associated with greater risk of adverse perinatal outcomes in a second pregnancy. 
Results 
The descriptive statistics of the outcome measures and weight changes during the perinatal periods for our 
sample are shown in Table 1. (Maternal demographic characteristics at P2 are presented in the Supplemental 
Appendix). The average pregravid weight was 68.53 kg (standard deviation = 16.83). BMI category means were 
58.46, 73.41, and 95.58 kg for normal-weight (BMI < 25.0 kg/m2), overweight (BMI = 25.0–29.9 kg/m2), and 
obese (BMI ≥ 30.0 kg/m2) women, respectively. The average GWG for the total sample was 15.35 kg in first 
pregnancies and 13.17 kg in second pregnancies. Interpregnancy weight loss was 12.26 kg after a mean 
interpregnancy interval of 20.5 months (standard deviation = 13.4), which led to an average increase of 3.09 kg 
from pregravid weight to pre-P2 weight. Normal/underweight and overweight women had larger weight 
fluctuations than obese women in all perinatal periods: they gained approximately 3 kg more during both 
gestations and lost approximately 2 kg more during the interpregnancy period. Rates of gestational diabetes, 
gestational hypertension, cesarean birth, perinatal death, LGA, and macrosomia increased as maternal pregravid 
BMI increased. Incidence of SGA decreased with higher maternal BMI. 
The sequential effect of women’s weight in each perinatal period on subsequent periods (Aim 1) is shown 
in Table 2. The results are reported as the effect, measured in kilograms, of a 5-kg difference in weight in one 
period on the next period. For example, for each 5 kg (11 pounds) of greater pregravid weight, the average P1 
GWG in the sample was 0.37 kg smaller. Pregravid weight was less strongly associated with subsequent weight 
changes (P1 GWG) than weight effects across the other periods (see Supplemental Appendix). Maternal weight 
changes during P1, the interpregnancy period, and P2 were strongly and positively interrelated: for each 5-kg 
increase in P1 GWG, interpregnancy weight loss increased by 2.94 kg, and for each 5-kg increase in 
interpregnancy weight loss, P2 GWG increased by 1.87 kg. 
Table 2. Trajectory of Effects of Perinatal Weight Change on Weight in Subsequent Perinatal Periods 
Perinatal Period Effect On    
Pregnancy 1 GWG Interpregnancy Weight 
Loss 
Pregnancy 2 GWG 
All women (N = 24,795)    
 Pregravid –0.370∗ [–0.400, –0.339] 
  
 Pregnancy 1 
 




1.867∗ [1.767, 1.967] 
Normal weight (includes 
underweight; n = 14,566) 
   
 Pregravid 0.391∗ [0.286, 0.497] 
  
 Pregnancy 1 
 




1.730∗ [1.588, 1.872] 
Overweight (n = 5,866)    
 Pregravid –0.467∗ [–0.695, –0.238] 
  
 Pregnancy 1 
 




2.190∗ [2.039, 2.340] 
Obese (n = 4,363)    
 Pregravid –0.683∗ [–0.777, –0.588] 
  
 Pregnancy 1 
 




1.806∗ [1.603, 2.009] 
Note. Data are presented as average increase or decrease in kilograms [95% confidence interval] in Pregnancy 1 
(GWG), interpregnancy weight loss, and Pregnancy 2 GWG associated with a 5-kg increase in weight during the 
previous perinatal period (pregravid, Pregnancy 1, and interpregnancy, respectively). Results obtained using a 
fully recursive simultaneous equations model (full model reported in the Supplemental Appendix in Table A3). 
Pregnancy 1 GWG, interpregnancy weight loss, and Pregnancy 2 GWG are adjusted for weight changes in prior 
perinatal weight periods. Data source: Wisconsin births in PeriData.net database, 2006 through 2013. GWG = 
gestational weight gain. 
∗ p < .01. 
 
The effect of weight in one perinatal period on the next was different by BMI category. Normal/underweight 
women had greater P1 GWG for each 5-kg increase in pregravid weight, whereas overweight and obese women 
had lower P1 GWG for each 5-kg increment. For each 5-kg increase in P1 GWG, overweight and obese women 
lost less interpregnancy weight (2.5 kg and 2.7 kg, respectively) than normal-weight women (3.2 kg). For each 
5 kg of additional interpregnancy weight loss, overweight women had the greatest subsequent increase in P2 
GWG (2.19 kg) followed by obese (1.81 kg) and normal/underweight women (1.73 kg). 
We displayed the effects of the four perinatal periods on P2 maternal and neonatal outcomes for the full sample 
(see Figure 2) and for normal weight (see Figure 3), overweight (see Figure 4), and obese (see Figure 5) women 
as odds ratios (ORs). Odds ratios greater than 1 indicate increased odds of occurrence of the outcome; ORs less 
than 1 indicate a reduction in the odds of occurrence. Maternal and neonatal outcomes were affected by 
maternal weight changes during each of the four perinatal periods. Significant independent effects of greater 
weight change in each period were evident for the following adverse maternal and neonatal outcomes in P2: 
gestational diabetes, gestational hypertension, cesarean birth, LGA, macrosomia, SGA, and low birth weight. No 
significant effects were identified for the presence of congenital abnormalities and perinatal death. 
 
Figure 2. Odds ratios and 95% confidence intervals for a 5-kg change in weight during a perinatal period on the 
odds of maternal and neonatal outcomes in the second pregnancy: results for all women. Odds ratio of greater 
than 1 indicates increased odds of occurrence of the outcome for a 5-kg maternal weight change. Odds ratio of 
less than 1 indicates decreased odds of occurrence. Calculated with a fully recursive simultaneous equations 
model. Effects for congenital anomalies and perinatal death were not significant and are not included in this 
figure. Odds ratios by weight classifications and the full display of results of the simultaneous equation modeling 
for maternal outcomes and for neonatal outcomes are provided in the Supplemental Appendix in Tables A4, A5, 




Figure 3. Odds ratios and 95% confidence intervals for a 5-kg change in weight during a perinatal period on the 
odds of maternal and neonatal outcomes in the second pregnancy: results for normal-weight (including 
underweight) women. Odds ratio of greater than 1 indicates increased odds of occurrence of the outcome for a 
5-kg maternal weight change. Odds ratio of less than 1 indicates decreased odds of occurrence. Calculated with 
a fully recursive simultaneous equations model. Effects for congenital anomalies and perinatal death were not 
significant and are not included in this figure. Odds ratios by weight classifications and the full display of results 
of the simultaneous equation modeling for maternal outcomes and for neonatal outcomes are provided in 
the Supplemental Appendix in Tables A4, A5, and A6, respectively. Data source: Wisconsin births 
in PeriData.net database, 2006–2013. GWG = gestational weight gain. 
 
 
Figure 4. Odds ratios and 95% confidence intervals for a 5-kg change in weight during a perinatal period on the 
odds of maternal and neonatal outcomes in the second pregnancy: results for overweight women. Odds ratio of 
greater than 1 indicates increased odds of occurrence of the outcome for a 5-kg maternal weight change. Odds 
ratio of less than 1 indicates decreased odds of occurrence. Calculated with a fully recursive simultaneous 
equations model. Effects for congenital anomalies and perinatal death were not significant and are not included 
in this figure. Odds ratios by weight classifications and the full display of results of the simultaneous equation 
modeling for maternal outcomes and for neonatal outcomes are provided in the Supplemental Appendix in 
Tables A4, A5, and A6, respectively. Data source: Wisconsin births in PeriData.net database, 2006–2013. GWG = 
gestational weight gain. 
 
 
Figure 5. Odds ratios and 95% confidence intervals for a 5-kg change in weight during a perinatal period on the 
odds of maternal and neonatal outcomes in the second pregnancy: results for obese women. Odds ratio of 
greater than 1 indicates increased odds of occurrence of the outcome for a 5-kg maternal weight change. Odds 
ratio of less than 1 indicates decreased odds of occurrence. Calculated with a fully recursive simultaneous 
equations model. Effects for congenital anomalies and perinatal death were not significant and are not included 
in this figure. Odds ratios by weight classifications and the full display of results of the simultaneous equation 
modeling for maternal outcomes and for neonatal outcomes are provided in the Supplemental Appendix in 
Tables A4, A5, and A6, respectively. Data source: Wisconsin births in PeriData.net database, 2006–2013. 
 
Maternal and neonatal outcomes in P2 were independently associated with pregravid weight in P1, conditional 
on weight gain during both gestations and interpregnancy weight loss, but the effect was smaller than the 
effects of subsequent GWG and interpregnancy periods. Overall, the odds of P2 adverse maternal outcomes 
were 9% to 12% greater (gestational diabetes: OR = 1.089, 95% confidence interval [CI] = [1.068, 1.110]; 
gestational hypertension: OR = 1.124, 95% CI [1.104, 1.144]; cesarean birth: OR = 1.094, 95% CI [1.078, 1.111]) 
for every 5-kg increase in pregravid weight; however, these associations varied and were not significant across 
all of the pregravid BMI groups. Pregravid weight was also associated with the odds of P2 adverse neonatal 
outcomes; specifically, 5 kg of excess pregravid weight was associated with 11% greater risk for macrosomia 
(OR = 1.114, 95% CI [1.099, 1.130]) and 12% greater risk for LGA (OR = 1.119, 95% CI [1.105,1.13]) but reduced 
the odds by 8% for SGA (OR = 0.915, 95% CI [0.896, 0.934]) and 9% for low birth weight (OR = 0.907, 95% CI 
[0.879, 0.936]). 
Pregnancy 1 GWG and interpregnancy weight loss had opposite and offsetting effects on maternal and neonatal 
outcomes of P2. For each 5-kg increase in P1 GWG, there was 12% to 19% greater risk of gestational diabetes 
(OR = 1.150, 95% CI [1.090, 1.212]), gestational hypertension (OR = 1.188, 95% CI [1.131, 1.249]), and cesarean 
birth (OR = 1.124, 95% CI [1.081, 1.168]) and a 18% to 21% greater risk of LGA (OR = 1.211, 95% CI [1.170, 
1.253]), and macrosomia (OR = 1.179, 95% CI [1.134, 1.226]); however, each subsequent interpregnancy weight 
loss of 5 kg reduced these risks for maternal outcomes by 10% to 13% for gestational diabetes (OR = 0.904, 
95% CI [0.863, 0.946]), gestational hypertension (OR = 0.868, 95% CI [0.833, 0.904]), and cesarean birth (OR = 
0.890, 95% CI [0.861, 0.921]) and by 19% to 20% for LGA (OR = 0.808, 95% CI [0.784, 0.832) and macrosomia 
(OR = 0.799, 95% CI [0.772, 0.828]). Greater P1 GWG was associated with 15% to 19% reduction in the risk of 
SGA (OR = 0.851, 95% CI [0.809, 0.894]) and low birth weight (OR = 0.809, 95% CI [0.741, 0.882]) in P2, with 
subsequent interpregnancy weight loss increasing these risks by 15% for SGA (OR = 1.151, 95% CI [1.108, 1.195]) 
and 17% for low birth weight (OR = 1.166, 95% CI [1.102, 1.233]). 
Pregnancy 2 GWG had the strongest association with adverse maternal and neonatal outcomes in P2: each 5 kg 
of additional weight gained increased the risk of gestational hypertension by 25% (OR = 1.252, 95% CI [1.182, 
1.327]), cesarean birth by 15% (OR = 1.146, 95% CI [1.096, 1.198]), LGA by 42% (OR = 1.419, 95% CI [1.362, 
1.479]), and macrosomia by 46% (OR = 1.457, 95% CI [1.390, 1.528]) and reduced by 21% to 22% the risk of SGA 
(OR = 0.787, 95% CI [0.749, 0.827]) and low birth weight (OR = 0.784, 95% CI [0.723, 0.850]). An unexpected 
result was that greater P2 GWG was associated with 18% (OR = 0.823, 95% CI [0.771, 0.879]) lesser risk of 
gestational diabetes. 
In the analyses for pregravid BMI, normal/underweight and overweight women had greater increases in risks for 
the P2 adverse maternal and neonatal outcomes than obese women. Among obese women, the associations of 
maternal and neonatal risks in P2 with weight changes in the perinatal weight periods were weaker and included 
nonsignificant associations with gestational diabetes and low birth weight for P1 GWG, interpregnancy, and P2 
GWG. 
Discussion 
Weight changes during each perinatal period of risk were associated with weight changes in subsequent periods 
and contributed to risk of adverse maternal and neonatal outcomes in the second pregnancy. Maternal weight 
changes during first gestation, interpregnancy, and second gestation are strongly interrelated. Greater P1 GWG 
was associated with greater interpregnancy weight loss and was followed by greater P2 GWG. The magnitude of 
these maternal weight fluctuations was independently and jointly associated with risk for adverse P2 maternal 
and neonatal outcomes. Pregravid weight was a poor predictor for the magnitude of these perinatal weight 
fluctuations; however, it was an independent risk factor for adverse maternal and neonatal outcomes. 
The sequential effect of one perinatal period on the next, with each 5-kg incremental change in maternal weight 
associated with up to 3 kg of change in weight in subsequent periods, along with the independent associations 
of these weight fluctuations with maternal and neonatal outcomes in P2, are clinically significant. Monitoring 
the entire trajectory of pregnancy and interpregnancy weight changes for women of all weight classifications is 
an important component of health care for women that should be routine and valued. The goal of clinical weight 
surveillance and management should be to detect and mediate a rollercoaster-type pattern of weight changes 
because larger weight fluctuations are associated with greater risk of adverse maternal and neonatal outcomes. 
Incorporating the entire trajectory of prior gestational and interconception weight changes, along with pregravid 
BMI, in pregnancy risk assessments can provide an opportunity to more effectively identify women at risk for 
extreme weight fluctuations and poorer birth outcomes. This is particularly important for normal-weight and 
overweight women, who have larger up-and-down weight cycling than obese women; therefore, they may have 
the greatest risk for substantial subsequent weight changes and the associated adverse outcomes. 
Our findings provide support for the extension of current recommendations for healthy weight management 
before, during, and after pregnancy. Although emphasizing guidelines for healthy weight before and during 
pregnancy, clinicians typically provide greater attention and counseling to women with elevated pregravid BMIs 
to address the well-known risks for adverse maternal and neonatal outcomes. This practice could explain why 
obese women in our study gained less weight during P1 and why their interpregnancy weight loss and P2 GWG 
were less than those of normal-weight and overweight women. However, because of the sensitivity of weight 
discussions, providers may avoid these discussions with normal-weight women, whom they see as at a lesser risk 
for weight-related complications (Stotland et al., 2010). Our results show that normal-weight women may be 
more susceptible to adverse maternal and neonatal outcomes than overweight or obese women because of 
larger weight fluctuations across the perinatal periods of risk. Among normal-weight women, an increased focus 
on recommended gain and loss of gestational weight, nutrition, and physical activity to prevent excessive weight 
cycling is a proactive strategy to reduce the risk of poor maternal and neonatal outcomes. 
Clinical counseling to promote effective weight management should occur at every prenatal, pregnancy, and 
interpregnancy health care visit, especially for women with excessive gain in pregnancy or larger-than-expected 
loss after birth. The finding that the effect of P1 GWG on adverse maternal and neonatal outcomes in a second 
pregnancy can be nearly fully offset by subsequent weight loss is encouraging. When women are counseled and 
monitored by professionals, interpregnancy weight loss can correct or compensate for excessive GWG. 
However, as our findings illustrate, women who lose more during interpregnancy periods are also very prone to 
gaining more in subsequent pregnancies and experiencing the associated adverse outcomes. Not regaining the 
excessive weight during a second gestation is equally important and may require significant effort. 
A surprising finding in our study was the negative association of the odds of P2 gestational diabetes with P2 
GWG (i.e., lower P2 gestational diabetes odds associated with greater P2 GWG), evident in the total sample and 
each BMI category. Given that increased weight in the prior periods was associated with greater risk of 
gestational diabetes in P2, and because we controlled for the occurrence of gestational diabetes in P1, a 
plausible explanation may be that women with gestational diabetes during P2 may be more attentive to GWG. 
Women diagnosed with glucose intolerance or gestational diabetes in a prior pregnancy are advised early in the 
pregnancy to be more attuned to healthy eating and control of GWG. The inverse effect of GWG on gestational 
diabetes may not have been evident in earlier studies in which researchers did not examine the association of 
gestational diabetes with weight gain in the second pregnancy. 
Weight surveillance and counselling in each perinatal period are essential to improve maternal and 
neonatal outcomes. 
Limitations 
Our study had several limitations. The generalizability of the findings of this retrospective study is limited by the 
source data, which included a portion of the population of a single U.S. state; the frequency of in-state repeated 
pregnancies and the demographic characteristics of the sample are not representative of the state or national 
population. Advancements in perinatal care and attention by health care providers and women themselves to 
weight management during childbearing may result in different findings in future studies with similar methods. 
The study sample included only first and second pregnancies; the effect on later pregnancies was not evaluated 
because the sample size became smaller, and estimates of effect were less reliable. 
We combined underweight and normal-weight women into a single category for analysis. We did not exclude 
underweight women because pregravid weights are often biased by self-reported weight and because excluding 
them did not change the results in sensitivity testing. There may be error in weight measures based on when 
and how weight was obtained and recorded by providers. The data entered by hospital personnel may include 
standard administrative record errors. The inclusive dates for the sample from 2006 through 2013 biases the 
sample toward a short interpregnancy interval (mean interpregnancy interval = 20.5 months). In sensitivity 
analyses to determine the effects of short (<18 months) and medium (18–60 months) interpregnancy intervals 
(Copen, Thoma, & Kirmeyer, 2015), the magnitudes were similar to the main findings, but effect sizes in the 
short interpregnancy interval subsample were slightly larger than in the medium interpregnancy interval 
subsample. No information was available in the data set on breastfeeding duration. The effect of breastfeeding 
duration on weight trajectory in the second pregnancy is not known and should be considered in future 
replications of this study and in prospective investigations. 
Conclusions 
Larger weight changes in the pregravid and gestational periods of the first pregnancy, the interpregnancy 
period, and second gestation increase the risk of adverse maternal and neonatal outcomes in the second 
pregnancy. Our findings indicate the importance of recommendations from the Institute of Medicine 
(Rasmussen & Yaktine, 2009) for maternal weight surveillance and management during each individual perinatal 
weight period in the childbearing cycle and highlight the need for attention to women in all BMI categories, 
including women of normal pregravid weight. The history of weight changes during and after a prior pregnancy 
is clinically useful for early identification of women with weight change patterns that increase risk for adverse 
outcomes. A comprehensive approach to risk assessment and perinatal weight management at each perinatal 
and interpregnancy health visit for all women regardless of their weight can improve maternal and neonatal 
outcomes. 
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